Science

Single Protein May Be Holding Back CAR T Cancer Therapy

Researchers identified NFIL3 as a major obstacle causing engineered immune cells to become exhausted and lose their cancer-fighting power, offering new hope for improving treatment of solid tumors.

Single Protein May Be Holding Back CAR T Cancer Therapy
Read the full reporting at ScienceDaily Top.

Originally reported by ScienceDaily Top.

CAR T therapy cancer treatment immunotherapy NFIL3 protein solid tumors gene editing